GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study

Ansari, M.; Curtis, P.H.D.; Uppugunduri, C.R.S.; Rezgui, M.A.; Nava, T.; Mlakar, V.; ... ; Krajinovic, M. (2017)

Article / Letter to editor

• busulfan
• pharmacokinetics
• pharmacogenetics
• toxicity
• hematopoietic stem cell transplantion

• All authors: Ansari, M.; Curtis, P.H.D.; Uppugunduri, C.R.S.; Rezgui, M.A.; Nava, T.; Mlakar, V.; Lesne, L.; Theoret, Y.; Chalandon, Y.; Dupuis, L.L.; Schechter, T.; Bartelink, I.H.; Boelens, J.J.; Bredius, R.; Dalle, J.H.; Azarnoush, S.; Sedlacek, P.; Lewis, V.; Champagne, M.; Peters, C.; Bittencourt, H.; Krajinovic, M.
• Date: 2017-10-31
• Journal: Oncotarget
• Volume: 8
• Issue: 53
• Pages: 90852 - 90867
• DOI: doi:10.18632/oncotarget.20310